DENVER INVESTMENT ADVISORS LLC - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 31 filers reported holding CANCER GENETICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DENVER INVESTMENT ADVISORS LLC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2015$42,000
-62.2%
12,699
-10.2%
0.00%
-60.0%
Q3 2015$111,00014,1410.01%
Other shareholders
CANCER GENETICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 581,200$1,157,0001.33%
Fairbanks Capital Management, Inc. 233,170$464,0000.56%
DIKER MANAGEMENT LLC 29,815$59,0000.02%
SABBY MANAGEMENT, LLC 199,580$397,0000.02%
Sterneck Capital Management, LLC 14,750$29,0000.02%
Spot Trading L.L.C 151,900$302,0000.01%
Acrospire Investment Management LLC 3,514$7,0000.01%
EAGLE GLOBAL ADVISORS LLC 84,320$168,0000.01%
BECK MACK & OLIVER LLC 18,225$36,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 47,600$94,0000.00%
View complete list of CANCER GENETICS INC shareholders